Olr526 inhibitors represent a specific chemical class that targets the activity of the Olr526 receptor, a protein encoded by the Olr526 gene. This receptor is a member of the olfactory receptor family, which is part of the larger G-protein-coupled receptor (GPCR) superfamily. Olr526 is involved in the detection of specific odorants, playing a role in olfactory signal transduction. Inhibitors of Olr526 are designed to interact with the receptor's binding site, either competitively or non-competitively, to prevent its normal function in signal transduction. These inhibitors may have distinct chemical structures but share a common mechanism of action focused on altering the receptor's conformation or its interaction with G-proteins, which are crucial for downstream signaling pathways.
The structural diversity of Olr526 inhibitors reflects the complexity of their interactions with the receptor. These molecules often feature hydrophobic and aromatic functional groups that align with the binding pocket of Olr526, optimizing their interaction with the receptor's ligand-binding domain. Additionally, some inhibitors might possess conformational flexibility, allowing them to adapt to the dynamic nature of the receptor's binding site. Understanding the binding kinetics and the specific molecular interactions between Olr526 inhibitors and their target receptor is key to unraveling the fundamental mechanisms underlying olfactory signal modulation. Research in this area not only expands knowledge of olfactory receptor biology but also provides valuable insights into the design of molecules that can precisely modulate GPCR activity, contributing to broader fields such as molecular biology and chemical signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BYL719 | 1217486-61-7 | sc-391001 sc-391001A sc-391001B sc-391001C sc-391001D sc-391001E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $391.00 $597.00 $755.00 $1192.00 $5000.00 $9370.00 | 2 | |
Inhibits PI3K, potentially altering proteins involved in the AKT/mTOR signaling pathway. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation. | ||||||
Capecitabine | 154361-50-9 | sc-205618 sc-205618A sc-205618B | 250 mg 1 g 5 g | $64.00 $208.00 $322.00 | 16 | |
Metabolized to 5-FU, potentially affecting proteins involved in DNA synthesis and repair. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $87.00 $332.00 $1093.00 | 16 | |
Microtubule inhibitor, potentially affecting cell division and mitotic proteins. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Inhibits EGFR tyrosine kinase, potentially affecting proteins in the EGFR signaling pathway. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Inhibits Bruton's tyrosine kinase, potentially affecting proteins in B-cell receptor signaling. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Dual inhibitor of EGFR and HER2, potentially affecting proteins in associated signaling pathways. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
PARP inhibitor, potentially affecting proteins involved in DNA repair pathways. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $130.00 $182.00 | 2 | |
Inhibits VEGF receptors, potentially affecting proteins involved in angiogenesis and tumor growth. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Inhibits multiple kinases, potentially affecting proteins in cell signaling and growth pathways. | ||||||